European Journal of Internal Medicine
Volume 20, Issue 1 , Pages 30-34, January 2009

Safety of furosemide administration in an elderly woman recovered from thiazide-induced hyponatremia

  • Safia Fadel

      Affiliations

    • Department of Internal Medicine, Hôpital Erasme, 808, route de Lennik 1070 Brussels Belgium, Université Libre de Bruxelles, U.L.B, Belgium
  • ,
  • Rafik Karmali

      Affiliations

    • Departement on Internal Medicine, CHU Brugmann., 4, place Van Gehuchten 1020 Brussels, Belgium, Université Libre de Bruxelles, U.L.B, Belgium
  • ,
  • Elie Cogan

      Affiliations

    • Department of Internal Medicine, Hôpital Erasme, 808, route de Lennik 1070 Brussels Belgium, Université Libre de Bruxelles, U.L.B, Belgium
    • Corresponding Author InformationCorresponding author. Department of internal medicine, Hôpital Erasme, 808, route de Lennik 1070 Brussels Belgium. Tel.: +3225553806; fax: +3225553211.

Received 21 October 2007; received in revised form 20 March 2008; accepted 25 April 2008. published online 19 June 2008.

Abstract 

Background

Elderly women are at risk to develop severe hyponatremia after thiazide but not loop diuretic administration. In patients with previous thiazide-induced hyponatremia, the risk for recurrent hyponatremia after furosemide has not been established.

Methods

In order to determine how both diuretics affect water metabolism, we here compare the effects of a rechallenge with either amiloride-hydrochlorothiazide fixed association (AmHTZ; amiloride chlorhydrate 5 mg+hydrochlorothiazide 50 mg; Moduretic™) or furosemide (F; 40 mg; Lasix™) on water excretion in a 79 year old woman who was previously admitted for severe symptomatic hyponatremia secondary to a 5 days course of AmHTZ for systolic hypertension. After correction of initial hydromineral disturbances, a standard oral water load (WL; 20 mL per kg body weight) was administered before, during and after AmHTZ or F challenges.

Results

Hyponatremia developed after AmHTZ but not after F challenge. A negative free water clearance (CH2O) was only observed during AmHTZ (−0.39 mL/min), while maximal CH2O during F was 3.17 mL/min. Based on the results obtained during WL, the calculated maximal daily electrolyte free water clearance ability was only 888 mL after AmHTZ but 10,166 mL after F therapy. Taking into account a measured mean daily water intake of 1830 mL, severe hyponatremia could be predicted to occur after a few days treatment with AmHTZ. In comparison, F appears to be safer, without risk of hyponatremia, during an equivalent period of time.

Conclusions

We here showed that F may be administered to a patient with previous AmHTZ induced hyponatremia without risk for recurrent hyponatremia.

Keywords: Hyponatremia, Thiazide, Furosemide, Hypertension, Free water excretion, Elderly

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0953-6205(08)00135-0

doi:10.1016/j.ejim.2008.04.006

European Journal of Internal Medicine
Volume 20, Issue 1 , Pages 30-34, January 2009